NIVF
NewGenIvf Group LimitedNASDAQHealthcare$2.19+9.39%ClosedMarket Cap: $1.2M
As of 2026-04-09
Valuation
P/E (TTM)
0.07
PEG
0.00
P/B
0.05
P/S
0.46
EV/EBITDA
0.56
DCF Value
$0.81
FCF Yield
-510.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.7%
Operating Margin
-276.6%
Net Margin
338.2%
ROE
32.7%
ROA
28.0%
ROIC
-24.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $1.3M | 9.2% | $-2.5M | $16.8M | $28.60 | — |
| Q4 2024 | $1.3M | 28.2% | $-1.1M | $-108.0K | $-4.60 | — |
| FY 2024 | $5.4M | 33.6% | $-1.2M | $-525.0K | $-22.31 | — |
| Q3 2024 | $1.5M | 43.9% | $216.3K | $-19.9K | $-1.31 | — |
| Q4 2023 | $1.5M | 13.0% | $-1.3M | $-955.0K | $31.98 | — |
| FY 2023 | $5.1M | 32.7% | $42.2K | $130.2K | $12.44 | — |
| Q3 2023 | $0.00 | NaN% | $-377.7K | $127.0K | $22.69 | — |
| Q2 2023 | $0.00 | NaN% | $-367.0K | $85.5K | $15.24 | — |
| Q1 2023 | $0.00 | NaN% | $-510.5K | $52.1K | $9.29 | — |
| Q4 2022 | $0.00 | NaN% | $-115.6K | $474.4K | $52.79 | — |
| FY 2022 | $5.9M | 25.9% | $-504.9K | $458.7K | $62.52 | — |
| Q3 2022 | $0.00 | NaN% | $-106.6K | $208.3K | $23.18 | — |